Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration

Vaccine

Volumn 15, Issue 11, 1997, Pages 1276-1285

  Delmastro, P ^a   Meola, A ^a   Monaci, P ^a   Cortese, R ^a   Galfre G ^a  

^a IRBM   (Italy)

Author keywords

Mimotopes; Oral immunogens; Phage

Indexed keywords

CHOLERA TOXIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIGEN; IMMUNOGLOBULIN A ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTRAGASTRIC DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHAGE DISPLAY; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; BACTERIOPHAGES; CHOLERA TOXIN; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN A; INTUBATION, GASTROINTESTINAL; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES;

EID: 0030796474     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00072-8     Document Type: Article

References (42)

1. Dulbecco, R. US Patent 1986. No. 4 593 002.
2. Smith, G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228, 1315.
3. Devlin, J.J., Panganiban, L.C. and Devlin, P.E. Random peptide libraries: a source of specific protein binding molecules. Science 1990, 249, 404.
4. Cwirla, S.E., Peters, E.A., Barrett, R.W. and Dower, W.J. Peptides on phage: a vast library of peptides for identifying ligands. Proceedings of the National Academy of Sciences of the United States of America 1990, 87, 6378.
5. Scott, J.K. and Smith, G.P. Searching for peptide ligands with an epitope library. Science 1990, 249, 386.
6. Hoess, R., Brinkmann, U., Handel, T. and Pastan, I. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody. Gene 1993, 128, 43.
7. Felici, F., Castagnoli, L., Musacchio, A., Jappelli, R. and Cesareni, G. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. Journal of Molecular Biology 1991, 222, 301.
8. Cortese, R., Monaci, P., Nicosia, A., Luzzago, A., Felici, F., Galfre, G., Pessi, A., Tramontano, A. and Sollazzo, M. Identification of biologically active peptides using random libraries displayed on phage. Current Opinions in Biotechnology 1995, 6, 73.
9. Folgori, A., Tafi, R., Meola, A., Felici, F., Galfre, G., Cortese, R., Monaci, P. and Nicosia, A. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO Journal 1994, 13, 2236.
10. de la Cruz, V.F., Lal, A.A. and McCutchan, T.F. Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. Journal of Biological Chemistry 1988, 263, 4318.
11. Greenwood, J., Willis, A.E. and Perham, R.N. Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium faciparum circumsporozoite protein as antigens. Journal of Molecular Biology 1991, 220, 821.
12. Meola, A., Delmastro, P., Monaci, P., Luzzago, A., Nicosia, A., Felici, F., Cortese, R. and Galfre, G. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. Journal of Immunology 1995, 154, 3162.
13. Motti, C., Nuzzo, M., Meola, A., Galfre, G., Felici, F., Cortese, R., Nicosia, A. and Monaci, P. Recognition by human sera and immunogenicity of HBsAg minotopes selected from an M13 phage display library. Gene 1994, 146, 191.
14. Muller, C.P. Mucosal vaccines: high-tech reagents for low-tech immunization. Immunology Today 1994, 15 (10), 458.
15. Staats, H.F., Jackson, R.J., Marinaro, M., Takahashi, I., Kiyono, H. and McGhee, J.R. Mucosal immunity to infection with implications for vaccine development. Current Opinions in Immunology 1994, 6, 572.
16. Walker, R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994, 12, 387.
17. Prezzi, C., Nuzzo, M., Meola, A., Delmastro, P., Galfre, G., Cortese, R., Nicosia, A. and Monaci, P. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. Journal of Immunology 1996, 156, 4504.
18. Smith, G.P. and Scott, J.K. Libraries of peptides and proteins displayed on filmentous phage. Methods in Enzymology 1993, 217, 228.
19. Haneberg, B., Kendall, D., Amerongen, H.M., Apter, F.M., Kraehenbuhl, J.P. and Neutra, M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infection and Immunity 1994, 62, 15.
20. Tanaka, M., Takeda, Y. and Takeo, S. Serum antibody production by oral immunization with dextran B512. Journal of Immunological Methods 1993, 159, 245.
21. Elson, C.O. and Ealding, W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. Journal of Immunology 1984, 132, 2736.
22. Liang, X.P., Lamm, M.E. and Nedrud, J.G. Oral adminisration of cholera toxin-Sendai virus conjugate poteniates gut and respiratory immunity against Sendai virus. Journal of Immunology 1988, 141, 1495.
23. Lycke, N. and Holmgren, Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. J. Immunology 1986, 59, 301.
24. Tamura, S., Yamanaka, A., Shimohara, M., Tomita, T., Komase, K., Tsuda, Y., Suzuki, Y., Nagamine, T., Kawahara, K. and Danbara, H. et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 419.
25. Wilson, A.D., Clarke, C.J. and Stokes, C.R. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scandinavian Journal of Immunology 1990, 31, 443.
26. Clarke, C.J., Wilson, A.D., Williams, N.A. and Stokes, C.R. Mucosal priming of T-lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant. Immunology 1991, 72, 323.
27. Nedrud, J.G., Liang, X.P., Hague, N. and Lamm, M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. Journal of Immunology 1987, 139, 3484.
28. Wu, H.Y. and Russell, M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infection and Immunity 1993, 61, 314.
29. Langermann, S., Palaszynski, S., Sadziene, A., Stover, C.K. and Koenig, S. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 1994, 372, 552.
30. Willis, A.E., Perham, R.N. and Wraith, D. Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage. Gene 1993, 128, 79.
31. Hanson, D.G. Ontogeny of orally induced tolerance to soluble proteins in mice. I. Priming and tolerance in newborns. Journal of Immunology 1981, 127, 1518.
32. Mowat, A.M. The regulation of immune responses to dietary protein antigens. Immunology Today 1987, 8, (3), 93.
33. Weiner, H.L., Mackin, G.A., Matsui, M., Orav, E.J., Khoury, S.J., Dawson, D.M. and Hafler, D.A. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis [see comments]. Science 1993, 259, 1321.
34. Miller, A., Lider, O., Abramsky, O. and Weiner, H.L. European Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune responses encephalomyelitis in adult animals. Journal of Immunology 1994, 24, 1026.
35. Nagler Anderson, C., Bober, L.A., Robinson, M.E., Siskind, G.W. and Thorbecke, G.J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proceedings of the National Academy of Sciences of the United States of America 1986, 83, 7443.
36. Miller, A., Hafler, D.A. and Weiner, H.L. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseaes. FASEB Journal 1991, 5, 2560.
37. Zhang, Z.J., Davidson, L., Eisenbarth, G. and Weiner, H.L. Suppression of diabetes in monobese diabetic mice by oral administration of porcine insulin. Proceedings of the National Academy of Sciences of the United States of America 1991, 88, 10252.
38. Trentham, D.E., Dynesius Trentham, R.A., Orav, E.J., Combitchi, D., Lorenzo, C., Sewell, K.L., Hafler, D.A. and Weiner, H.L. Effects of oral administration of type II collagen on rheumatoid arthritis [see comments]. Science 1993, 261, 1727.
39. Weiner, H.L. Oral tolerance [comment]. Proceedings of the National Academy of Sciences of the United States of America 1994, 91, 10762.
40. Tsunetsugu Yokota, Y., Tatsumi, M., Robert, V., Devaux, C., Spire, B., Chermann, J.C. and Hirsch, I. Expression of an immunogenic region of HIV by a filamentous bacteriophage vector. Gene 1991, 99, 261.
41. Schodel, F. Prospects for oral vaccination using recombinant bacteria expressing viral epitopes. Advances in Virus Research 1992, 41, 409.
42. Cardenas, L., Dasgupta, U. and Clements, J.D. Influence of stain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine 1994, 12, 833.